Showing results (91-100 of 442) with videos related to

Sort By:
Pageof 45
Drug Safety|September 15, 2022
Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the NetherlandsEsther de Vries, Elisabeth Bakker, Taco B M Monster, et al.
Diabetes, Obesity & Metabolism|April 25, 2018
HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroupsGrigory Sidorenkov, Job F M van Boven, Trynke Hoekstra, et al.
Clinical Epidemiology|January 31, 2023
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes MellitusFan Zhang, Geertruida H de Bock, Petra Denig, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 14, 2015
Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic reviewD P Martono, R Lub, H J Lambers Heerspink, et al.
Family Practice|January 7, 2000
GPs' treatment of uncomplicated urinary tract infections--a clinical judgement analysis in four European countries. DEP group. Drug Education ProjectE Hummers-Pradier, P Denig, T Oke, et al.
Plos One|August 29, 2019
When drug treatments bias genetic studies: Mediation and interactionAmand F Schmidt, Hiddo J L Heerspink, Petra Denig, et al.
Atherosclerosis|May 25, 2018
Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: The LifeLines cohortJeroen K de Vries, Jan W Balder, Michelle J Pena, et al.
Quality & Safety in Health Care|April 30, 2010
Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burdenJ Voorham, F M Haaijer-Ruskamp, B H R Wolffenbuttel, et al.
Frontiers in Pharmacology|February 11, 2022
Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk MarkersSok Cin Tye, Sieta T de Vries, Christoph Wanner, et al.
Clinical Therapeutics|March 15, 2011
Medication adherence affects treatment modifications in patients with type 2 diabetesJaco Voorham, Flora M Haaijer-Ruskamp, Bruce H R Wolffenbuttel, et al.
Pageof 45